Cellular Biomedicine reports 3Q loss

CUPERTINO, Calif. (AP) _ Cellular Biomedicine Group Inc. (CBMG) on Thursday reported a loss of $6.2 million in its third quarter.

On a per-share basis, the Cupertino, California-based company said it had a loss of 43 cents.

The biotechnology company posted revenue of $106,800 in the period. Its adjusted revenue was $107,000.

Cellular Biomedicine shares have fallen 21 percent since the beginning of the year. The stock has dropped 8 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CBMG at https://www.zacks.com/ap/CBMG